Log In
BCIQ
Print this Print this
 

Px563L

  Manage Alerts
Collapse Summary General Information
Company Pfenex Inc.
DescriptionRecombinant protective antigen (rPA) anthrax vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationAnthrax
Indication DetailsTreat and prevent anthrax infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today